Gynecologic Oncology | Specialty

Age Cutoff for Pap Tests Questioned

May 2nd 2011

More than 12% of newly diagnosed cervical cancers occurred in women aged 70 to 85 years during 2000 to 2006

Dr. Karlan Describes AMG 386 Side Effects

April 29th 2011

Dr. Karlan Describes AMG 386 Side Effects Found in the Phase II Ovarian Cancer Trial

Tinkering With Regimen Leads to Better Outcomes in Vulvar Cancer

April 29th 2011

Investigators in a cooperative group trial reported that modifications in a chemoradiation regimen for locally advanced vulvar cancer boosted both clinical and pathologic complete response rates

MicroRNA May Predict Response to Bevacizumab

April 28th 2011

The results of a small clinical trial showed that low-level expression of a microRNA correlated with improved progression-free survival

Study Indicates Cetuximab Provides No Benefit in Advanced Cervical Cancer

April 28th 2011

Results of a phase II cooperative-group trial showed that the targeted agent cetuximab demonstrated minimal activity in patients with advanced, platinum-resistant cervical cancer

Dr. Carey Discusses the Need for Targeted Therapy in TNBC

April 26th 2011

Dr. Lisa Carey Discusses the Need for Targeted Therapy in Triple Negative Breast Cancer (TNBC)

FDA Grants NKTR-102 Orphan Drug Status for Treatment of Ovarian Cancer

April 26th 2011

Nektar Therapeutics announced that its oncology drug candidate, NKTR-102, has been granted orphan drug status

Phase II AMG 386 and Paclitaxel Combination Trial

April 26th 2011

Analysis of the Phase II AMG 386 and Paclitaxel Combination Trial

Study Finds that Air Pollution Can Lead to Breast Cancer

April 21st 2011

Exposure to air pollution at certain times in a woman's life can leave her more susceptible to premenopausal breast cancer

FDA Approves New Test for HPV

April 20th 2011

Cervical cancer affects about 470,000 women each year and now the disease has a new tool to combat its spread

New Study Findings Change the Standard of Care for Women With Breast Cancer

April 19th 2011

Contrary to the traditionally slow pace of research adoption, the American College of Surgeons Oncology Group's Z0011 trial has seemingly changed practice overnight

The Meaning of Breast Cancer Risk and Surveillance Behaviors Among High-Risk African-American Women

April 15th 2011

A breast cancer diagnosis is a highly distressing, life-changing experience

Taking Measures to Prevent Breast Cancer

April 5th 2011

A team of researchers explored the use of drugs in terms of breast cancer prevention strategies

Rocky Ride for Iniparib Not Yet Over

April 1st 2011

Iniparib remains an intriguing therapeutic possibility despite failing to meet its phase III primary endpoints

Dr. Twelves on the Value of the Iniparib Trial Results

April 1st 2011

Christopher Twelves, MD, Professor of Clinical Cancer Pharmacology and Oncology and Head of the Clinical Cancer Research Group at the University of Leeds in the United Kingdom on the Value of the Negative Iniparib Trial Results

Fewer Women Dying of Lung Cancer

April 1st 2011

For the first time in at least 3 decades, the rate of women dying from lung cancer in the United States is declining

Dr. Twelves on Negative Phase III Iniparib Announcements

April 1st 2011

Dr. Twelves Describes Iniparib Clinical Trials

April 1st 2011

March Net Guides: Ovarian Cancer

March 31st 2011

Useful Online Resources and Clinical Trials for Ovarian Cancer

Lymph Nodes Overlooked in Ovarian Cancer Patients

March 30th 2011

Women with early-stage ovarian cancer were nearly twice as likely to die if they did not have recommended staging biopsies of pelvic and aortic lymph nodes